87 related articles for article (PubMed ID: 28881777)
1. OVA12 promotes tumor growth by regulating p53 expression in human cancer cells.
Zhang R; Wu X; Xia X; Khanniche A; Song F; Zhang B; Wang Y; Ge H
Oncotarget; 2017 Aug; 8(32):52854-52865. PubMed ID: 28881777
[TBL] [Abstract][Full Text] [Related]
2. OVA12, a novel tumor antigen, promotes cancer cell growth and inhibits 5-fluorouracil-induced apoptosis.
Zhang R; Jin S; Rao W; Song F; Yin Q; Wang Y; Wang L; Xi Y; Zhang X; Wang M; Ge H
Cancer Lett; 2015 Feb; 357(1):141-151. PubMed ID: 25444895
[TBL] [Abstract][Full Text] [Related]
3. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
4. p53 protein aggregation promotes platinum resistance in ovarian cancer.
Yang-Hartwich Y; Soteras MG; Lin ZP; Holmberg J; Sumi N; Craveiro V; Liang M; Romanoff E; Bingham J; Garofalo F; Alvero A; Mor G
Oncogene; 2015 Jul; 34(27):3605-16. PubMed ID: 25263447
[TBL] [Abstract][Full Text] [Related]
5. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
6. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
Brignone C; Bradley KE; Kisselev AF; Grossman SR
Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth JA; Tschopp J; Tanaka N
Oncogene; 2001 Aug; 20(37):5225-31. PubMed ID: 11526513
[TBL] [Abstract][Full Text] [Related]
9. COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.
Dornan D; Bheddah S; Newton K; Ince W; Frantz GD; Dowd P; Koeppen H; Dixit VM; French DM
Cancer Res; 2004 Oct; 64(20):7226-30. PubMed ID: 15492238
[TBL] [Abstract][Full Text] [Related]
10. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
13. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
Joseph TW; Zaika A; Moll UM
FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
[TBL] [Abstract][Full Text] [Related]
15. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.
Kurdistani SK; Arizti P; Reimer CL; Sugrue MM; Aaronson SA; Lee SW
Cancer Res; 1998 Oct; 58(19):4439-44. PubMed ID: 9766676
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-proteasome system is inhibited by p53 protein expression in human ovarian cancer cells.
Hwang IY; Baguley BC; Ching LM; Gilchrist CA
Cancer Lett; 2010 Aug; 294(1):82-90. PubMed ID: 20153923
[TBL] [Abstract][Full Text] [Related]
18. p53 and PPP1R13L (alias iASPP or RAI) form a feedback loop to regulate genotoxic stress responses.
Laska MJ; Vogel UB; Jensen UB; Nexø BA
Biochim Biophys Acta; 2010 Dec; 1800(12):1231-40. PubMed ID: 20840860
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
